Answers are grounded in this paper and cite their sources.
Moxidectin administered orally at 24 µg/kg to dogs for four or six consecutive months was ≥ 95.9% effective in preventing the development of two ML-resistant heartworm strains and resulted in significantly fewer adult D. immitis than in dogs treated with Heartgard® Plus or Interceptor® Plus when administered for six consecutive months at their approved label dosages in two laboratory efficacy studies.
No takes yet. Share an insight, caveat, or question.
Kryda et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: